Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/c32596a9-d7e9-4610-ac4c-781999741dc3/

LMAT

LeMaitre Vascular Inc
Chart
$94.48
Latest Week 2026-06-05
HealthcareMedical Instruments & SuppliesMID
Snapshot 2026-06-07 · 0.0w · Fresh
0.38
OS Score
5.0%
Value
95.0%
Quality
68.0%
Momentum
7/9
F-Score
0.218
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
3 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
ROE 15%
📈
Consistent Earners
Noneyr
🌱
GARP
✗
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
12-1 29%
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
5.0%ile
P/E
34.9×
P/S
8.5×
P/B
5.4×
E/P
0.0287
FCF Yield
0.041
EBITDA/EV
0.039
SH Yield
0.009
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
96.00000000
/100 — 1=cheapest
VC2 (Trending Value)
94.00000000
/100
VC3 (Buyback)
94.00000000
/100
P/E of 34.9x is premium-priced — the market is paying up for expected growth. VC2 score of 94.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
95.0%ile
ROE
0.153
ROA
0.099
Net Margin
0.243
Op Margin
0.322
GPA
0.295
D/E
0.55
Current
14.32
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.133
Earn Growth
0.382
Stability
0.186
lower=better
Accruals
-0.040
lower=better
5yr Consist
Yes
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
68.0%ile
6M Return
12.3%
12M Return
13.4%
12-1 Mom
29.2%
Risk-Adj
0.88
Vol 252d
33.1%
Vol 60d
70.3%
↑ Expanding
Max DD 12M
-19.9%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of 29% is very strong — a clear uptrend. Near-term vol (70%) is expanding vs long-term (33%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.38
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
2.0%
Sector Quality %ile
95.8%
P/E z-score
0.17
P/B z-score
0.03
Sector Avg OS
63.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Quality at a Premium
High quality (95th) but expensive (5th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (70%) significantly exceeds 252-day (33%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
30.9% avg (7 factors)
Quality
A
76.5% avg (8 factors)
Momentum
C
55.1% avg (4 factors)
Risk
B
61.6% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.380—0—
Value %ile0.050—1—
Quality %ile0.950—1—
Momentum %ile0.680—0—
F-Score7.000—1—
Confidence1.000—1—
Volatility0.331—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
34.87
Earnings Yield (E/P)
0.0287
Price / Sales
8.49
Price / Book
5.35
Price / Cash Flow
24.92
FCF Yield
4.1%
EBITDA / EV
3.9%
Sales Yield (1/P·S)
0.1104
Shareholder Yield
Div + net buyback / mktcap
0.9%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
15.3%
Return on Assets
9.9%
Net Margin
24.3%
Operating Margin
32.2%
Gross Profit / Assets
Novy-Marx GPA
29.5%
Debt / Equity
0.55
Current Ratio
14.32
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.040
MomentumPrice trend strength over different horizons
6M Return
12.3%
12M Return
13.4%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
29.2%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.88
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
13.3%
Earnings Growth (YoY)
38.2%
Earnings Stability (CV)
Lower = more stable
0.186
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
7
Dividend Yield
0.9%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
96
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
94
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
94
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity